Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,841Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Votrient

PharmaCompass

01

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 635

2019 Revenue in Millions : 755

Growth (%) : -16

blank

02

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 577

2020 Revenue in Millions : 635

Growth (%) : -9

blank

03

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 474

2021 Revenue in Millions : 577

Growth (%) : -18

blank

04

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 390

2022 Revenue in Millions : 474

Growth (%) : -18

blank

05

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

06

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 0

2014 Revenue in Millions : 565

Growth (%) : New Launch

blank

07

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 729

2015 Revenue in Millions : 565

Growth (%) : 29

blank

08

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 808

2016 Revenue in Millions : 729

Growth (%) : 11

blank

09

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 828

2017 Revenue in Millions : 808

Growth (%) : 2%

blank

10

Brand Name : Votrient

Pazopanib

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Votrient

arrow
Medlab Asia & Asia Health
Not Confirmed

Pazopanib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 755

2018 Revenue in Millions : 828

Growth (%) : -9

blank